Artificial intelligence and machine learning hold tremendous potential to identify new molecules and accelerate drug development to deliver innovative medicines to patients faster. Clarivate analysts identified seven promising early-stage companies working on AI and machine learning applications for drug discovery and development and identified critical best practices and trends in this emerging technology, including:
- The astonishing growth in IP creation and scientific knowledge around AI/ML for the life sciences over the past decade
- The emergence of an AI/ML for life sciences hub in Mainland China to rival those in the United States
- Partnering strategies large pharmas are pursuing to incorporate potentially transformational AI/ML platforms into their R&D operations
Download the report to learn more about the trends shaping this fast-moving space and which AI/ML companies are ones to watch.
Got questions? To speak with one of our market specialists, please contact us here.
